President and Interim CFO Michael Field Acquires 43.4M Shares in Rights Offering, Boosting Stake to 31%
HSTC filed a Ownership and Investor Activity on light trading volume (0.1× avg).
Summary
President and Interim CFO Michael Field acquired 43.4 million shares of HST Global for $156,389.66 in a rights offering, increasing his total stake to 86.9 million shares (31% of the company). The purchase was funded with personal funds and debt conversion.
Key Events · Ownership and Investor Activity · HSTC
-
Insider Acquires 43.4M Shares
President and Interim CFO Michael Field purchased 43,441,573 shares for $156,389.66 in a shareholder rights offering, increasing his total holdings to 86,883,146 shares.
-
Stake Rises to 31%
Following the acquisition, Field beneficially owns 31% of HST Global's common stock, reinforcing his significant ownership position.
-
Funding from Personal Resources
The purchase was funded with $156,389.66 from personal funds, including cash and conversion of indebtedness, demonstrating personal financial commitment.
-
Rights Offering Structure
The transaction was a 1-for-1 rights purchase that did not change Field's percentage ownership, indicating proportional participation in the offering.
Analysis · HSTC · Life Sciences
A $156,389.66 personal commitment from President and Interim CFO Michael Field signals strong confidence in HST Global's future. Through a shareholder rights offering, he acquired 43.4 million shares, lifting his total holdings to 86.9 million shares, or 31% of the company. The purchase was funded with personal cash and debt conversion. Although the 1-for-1 structure left his percentage ownership unchanged, the substantial dollar outlay underscores a meaningful alignment of management and shareholder interests.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 28.9% of the 1666 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HSTC was trading at $0.70 on OTC in the Life Sciences sector, with a market capitalization of approximately $99M. The 52-week trading range was $0.00 to $1.15. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.